Crossmark

Treatment Options Available for COVID-19 and an Analysis on Possible Role of Combination of rhACE2, Angiotensin (1-7) and Angiotensin (1-9) as Effective Therapeutic Measure

Crossref DOI link: https://doi.org/10.1007/s42399-020-00407-9

Published Online: 2020-08-22

Published Print: 2020-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Muslim, Shahnawaz

Nasrin, Nasrin

Alotaibi, Faisal Obaid

Prasad, Geeta

Singh, Shambhu Kumar

Alam, Izhar

Mustafa, Gulam
License Information

Text and Data Mining valid from 2020-08-22

Version of Record valid from 2020-08-22
More Information

Article History

Accepted: 10 July 2020

First Online: 22 August 2020

Compliance with Ethical Standards

:

: The authors declare that they have no conflict of interest.

: No required

: Not required

Free to read: This content has been made available to all.

Document is current

Any future updates will be listed below